维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Macor P"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Complement as effector system in cancer immunotherapy 显示文摘	Macor P Tedeseo F	2007	Immunol Lett2007，111，1：	1
2	The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 显示文摘	Marzari R Sblattero D Macor P	2002	Eur J Immunol2002，32，10：	1
3	Left ventricular per-formance during prolonged exercise and early recovery inhealthy subjects显示文摘	Palatini P Bongiovi S Macor F	1994	Eur J Appl Physiol Occup Physiol1994，69，5：	1
4	Phage display technology for human monoclonal antibodies 显示文摘	Deantonio C Cotella D Macor P	2014	Methods Mol Biol2014，1060，：	1
5	Complement as effector system in cancer immuno- therapy显示文摘	Macor P Tedesco F	2007	Immunol Lett2007，111，1：	1
6	Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma显示文摘	Macor P	2006	Cancer Res2006，66，7：	1
7	Complement in human- diseases:lessons from eomplement deficiencies 显示文摘	Botto M Kirsehfink M Macor P	2009	Mol Immu- nol2009，46，：	1
8	Effect of strength training on blood pressure measured in various conditions in sedentary men显示文摘	Van Hoof R Macor F Lijnen P	1996	Int J Sports Med1996，17，6：	1
9	Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity显示文摘	MACOR C RUGGERI A MAZZONETTO P	1997	Metabolism1997，46，2：	1
10	Humoral immunotherapy of multiple myeloma: perspectives and perplexities 显示文摘	Di Bemardo A Macor P Guamotta C	2010	Expert Opin Biol Ther2010，10，6：	1
11	Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity显示文摘	Macor C Ruggeri A Mazzonetto P	1997	Metabolism1997，46，1：	1
12	Effect of strength training on blood pressure measured in various conditions in sedentary men显示文摘	VANHCK)F R MACOR F LIJNED P	1996	J Sports Med1996，17，：	1
13	Humoral immunotherapy of multiple myeloma:perspectives and perplexities显示文摘	Di Bernardo A Macor P Guarnotta C	2010	Expert Opin Biol The2010，10，：	1
14	The development of atypical hemolytic uremic syndrome depends on complement C5显示文摘	de Jorge EG Macor P Paixao-Cavalcante D	2011	J Am Soc Nephrol2011，22，：	1
15	Controlling complement resistance in cancer by using human monoelonal antibodies that neutralize complement- regulatory proteins CD55 and CD59显示文摘	Zillex F Macor P Bulla R	2005	Eur J Immunol2005，35，7：	1
16	Controlling complement resistance in cancer by using hmnan monoclonal antibodies thai neutralize complement-regulatory proteins CD55 and CD59 显示文摘	Ziller F Macor P Bulla R	2005	Eur J hnmu- nol2005，35，7：	1
17	Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize-complement-regulatory proteins CD55 and CD59显示文摘	Ziller F Macor P Bulla R	2005	Eur J Immunol2005，35，7：	1
18	The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 显示文摘	Marzari R Sblattero D Macor P	2002	Eur J Immunol2002，32，：	1
19	Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma 显示文摘	Macor P Mezzanzanica D Cossetti C	2006	Cancer Res2006，66，7：	1
20	Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 显示文摘	Ziller F Macor P Bulla R	2005	Immunol2005，35，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示